Clearline Capital LP Merrimack Pharmaceuticals Inc Transaction History

Clearline Capital LP

  • $2.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$3.19 - $5.73 $1.01 Million - $1.81 Million
-316,425 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$2.95 - $4.15 $13,068 - $18,384
-4,430 Reduced 1.38%
316,425 $1.22 Million
Q3 2018

Nov 14, 2018
BUY
$3.91 - $4.66 $1.02 Million - $1.22 Million
261,524 Added 440.79%
320,855 $1.71 Million
Q2 2018

Aug 14, 2018
BUY
$3.86 - $7.61 $229,017 - $451,508
59,331 New
59,331 $291,000

Others Institutions Holding MACK

# of Institutions
1
Shares Held
77
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Clearline Capital LP Portfolio

Follow Clearline Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email